Tuesday, October 23, 2018

Imprimis Pharmaceuticals' Subsidiary Melt Pharmaceuticals Initiates ...

P&T Community-15 hours ago
In addition to owning the nation's leading ophthalmology pharmaceutical compounding business, ImprimisRx, the Company holds large equity positions in Eton 
Post a Comment